MedTrace Logo

Fecal Microbiota Transplantation for Decompensated Cirrhosis

NCT03014505 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-01-09

No results posted yet for this study

Summary

Imbalance of gut bacteria is suspected to play a key role driving the progression of cirrhosis and there is hope manipulation of these bacteria may be beneficial. This study will determine if fecal microbiota transplantation is an effective and safe treatment for decompensated cirrhosis.

Conditions

  • Decompensated Cirrhosis
  • Fecal Microbiota Transplantation

Interventions

BIOLOGICAL

FMT

Fecal Microbiota Transplantation and the traditional treatments for Decompensated Cirrhosis in part 1

OTHER

traditional treatments

traditional treatments for Decompensated Cirrhosis in part 2

Sponsors & Collaborators

  • First Affiliated Hospital of Chengdu Medical College

    lead OTHER

Principal Investigators

  • Xiao-an Li, Ph.D · First Affiliated Hospital of Chengdu Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-03-31
Completion
2018-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03014505 on ClinicalTrials.gov